) The activities of the Clinical Investigations Shared Resource are centered around the Patient Referral Office. This resource is offered to member-investigators of the San Antonio Cancer Institute to support appropriate referral to and rapid completion of peer reviewed, funded clinical research projects and investigator-initiated pilot studies. The Patient Referral Office is the primary venue for patient access to cancer center clinical trials. The Patient Referral Coordinator accepts telephone inquiries from physicians, patients and others about the availability of clinical trials. Contacts by mail are also addressed through phone calls from this office. The Patient Referral Coordinator can assess preliminary patient eligibility by phone, assemble clinical data for review, and arrange an evaluation by a SACI physician-investigator. Since January 1, 1997, this office has accepted 1,255 telephone calls about access to clinical trials or cancer. These calls may be brief, single contacts or many initiate several hours or conversation and multiple follow-up calls between the coordinator and the referring oncologist, patient, protocol investigators and cancer center personnel. The Patient Referral Coordinator is equipped to provide callers with up- to-date eligibility and treatment about all therapeutic clinical research studies conducted at this cancer center, including all cooperative group studies, NCI Phase I Cooperative Agreement studies, investigator-initiated institutional pilot studies, and pharmaceutical company-sponsored studies conducted under the SACI Experimental Therapeutics Program, as well as the NSABP Breast Cancer Prevention Trial, the Intergroup Prostate Cancer Prevention Trial, and referrals for evaluation in the SACI Cancer Prevention and Risk Assessment Clinic related to studies conduced by the SACI Cancer Prevention and Health Promotion and Breast Cancer Programs. The Patient Referral Office has become an essential and central component of our cancer center's interactions with the community and with other cancer treatment facilities. The office provides an efficient mechanism for assuring the highest likelihood of matching a clinical trial with a patient's treatment needs. It is noteworthy that the Patient Referral Coordinator's special value to the clinical investigations programs of the SACI is her level of expertise in obtaining in-depth information from callers about their treatment needs, the caller's potential for participation in a SACI clinical trial, and developing realistic plans for the caller's further evaluation in our setting or that of another cancer center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-08
Application #
6102673
Study Section
Project Start
1998-08-06
Project End
1999-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Ctrc Research Foundation
Department
Type
DUNS #
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Deng, Yilun; Qin, Yuejuan; Srikantan, Subramanya et al. (2018) The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex. Hum Mol Genet 27:1794-1808
Wei, Zhen; Panneerdoss, Subbarayalu; Timilsina, Santosh et al. (2018) Topological Characterization of Human and Mouse m5C Epitranscriptome Revealed by Bisulfite Sequencing. Int J Genomics 2018:1351964
Chiang, Huai-Chin; Zhang, Xiaowen; Zhao, Xiayan et al. (2018) Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development. Sci Rep 8:2731
Zanotto-Filho, Alfeu; Rajamanickam, Subapriya; Loranc, Eva et al. (2018) Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells. Cancer Lett 425:101-115
Segovia, Jesus A; Chang, Te-Hung; Winter, Vicki T et al. (2018) NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection. Infect Immun 86:
Donegan, Jennifer J; Boley, Angela M; Lodge, Daniel J (2018) Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism. Neuropsychopharmacology 43:1789-1798
Vaidya, Anand; Flores, Shahida K; Cheng, Zi-Ming et al. (2018) EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease. N Engl J Med 378:1259-1261
Cepeda, Sergio; Cantu, Carolina; Orozco, Stephanie et al. (2018) Age-Associated Decline in Thymic B Cell Expression of Aire and Aire-Dependent Self-Antigens. Cell Rep 22:1276-1287
Snead, Wilton T; Zeno, Wade F; Kago, Grace et al. (2018) BAR scaffolds drive membrane fission by crowding disordered domains. J Cell Biol :
Ramasamy, Kumaraguruparan; Balasubramanian, Sowmya; Manickam, Krishnan et al. (2018) Mycoplasma pneumoniae Community-Acquired Respiratory Distress Syndrome Toxin Uses a Novel KELED Sequence for Retrograde Transport and Subsequent Cytotoxicity. MBio 9:

Showing the most recent 10 out of 989 publications